Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Archive

Hadassah Graduate Designs Programs That Decrease Death from HIV/AIDS and TB

Benson Ulo, a 2003 graduate of the International Masters of Public Health Program at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, applauds his education for providing him with a “flexible think tank,” where students are equipped to shape public health care worldwide.

Having struggled to gain admittance to medical school, Mr. Ulo found himself forced to interrupt his education. He took on odd jobs at construction sites, just to survive. Three years later, he was fortunate to get a sponsor, which made it possible for him to return to academia to study public health. He subsequently received a scholarship to attend the IMPH program in Jerusalem. This was “an opportunity of a lifetime,” he says, “and has led to multiple rewards in my life.”

Hadassah enables women to expand their horizons, take charge of their lives and provides opportunities to study Judaism, Zionism, Jewish history, Hebrew, literature and culture.

DONATE

Join

Advocate

Lead

LEARN MORE

View all of our Impact Areas

At international Medical Corps, his employer since 2004, Mr. Ulo says, his IMPH education has enabled him to design and implement HIV/AIDS and TB programs that have helped thousands of people, with both prevention and treatment in remote areas of his country. Mr. Ulo is currently the director of an HIV/AIDS and TB program in local prisons which, he reports, has greatly improved the health of inmates, bringing down the TB death rate from about 40 percent to zero!

Mr. Ulo shares his work experiences at international conferences and, as a result, believes he influences program design in many other countries.

Date: 12/18/2013


More hMedicine Stories




Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America